Author: Coave Therapeutics

Posted Date:

April 28, 2026

Coave Therapeutics to unveil OneAAVTM universal capsid at ASGCT 2026, paving the way for third generation gene therapy vectors

Coave Therapeutics

April 28, 2026
Coave Therapeutics to present two posters at ARVO 2026, on first-in-class ligand-conjugated suprachoroidal vector and lead gene therapy program

Coave Therapeutics

April 23, 2026